广东肇庆星湖生物科技股份有限公司 2025年半年度业绩预告

Core Viewpoint - The company, Guangdong Zhaoqing Xinghuo Biotechnology Co., Ltd., anticipates a significant increase in net profit for the first half of 2025, projecting a rise of over 50% compared to the same period last year [2][4]. Group 1: Performance Forecast - The company expects a net profit attributable to shareholders of the parent company to be between 790 million to 850 million yuan, an increase of 283.83 million to 343.83 million yuan, representing a year-on-year growth of 56.07% to 67.93% [2][4]. - The projected net profit, excluding non-recurring gains and losses, is estimated to be between 760 million to 820 million yuan, an increase of 225.69 million to 285.69 million yuan, reflecting a year-on-year increase of 42.24% to 53.47% [2][4]. Group 2: Previous Year’s Performance - In the first half of 2024, the total profit was 648.20 million yuan, with a net profit attributable to shareholders of the parent company at 506.17 million yuan, and a net profit excluding non-recurring gains and losses at 534.31 million yuan [6]. Group 3: Reasons for Performance Change - The company achieved improved performance in the first half of 2025 through enhanced internal management and the implementation of "three precision management" initiatives, leading to increased efficiency in production and operations [8]. - Additionally, a decrease in the procurement costs of key raw materials contributed to the overall optimization of product costs, positively impacting profit growth [8]. Group 4: Shareholder Information - As of the announcement date, the major shareholder, Ningxia Yipin Investment Group Co., Ltd., and its associated party hold a total of 233,036,630 shares, accounting for 14.03% of the company's total share capital [11]. - The shareholder, Tie Xiaorong, has released a pledge on 57,043,761 shares, which is 94.52% of his pledged shares, representing 3.43% of the total share capital [11][12]. - After the release of the pledge, Tie Xiaorong has no pledged shares remaining, while the total pledged shares by him and his associates amount to 89,351,604 shares, which is 38.34% of their total holdings and 5.38% of the total share capital [12][14].